Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Evgen Pharma ( (GB:TCF) ) has provided an announcement.
TheraCryf PLC, a UK-based company, has announced a change in its major holdings due to an acquisition or disposal of voting rights by James Robert Kight. The notification indicates that Kight’s voting rights have decreased from 8.09647% to 2.63427%, which may impact the company’s shareholder dynamics and influence in decision-making processes.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 1,742,780
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £1.15M
See more data about TCF stock on TipRanks’ Stock Analysis page.